Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹1,146.1 Cr | ₹1,109.8 Cr | ₹1,302.7 Cr | ₹1,374.8 Cr |
| Net Profit | ₹232.9 Cr | ₹225.3 Cr | ₹255.3 Cr | ₹273.8 Cr |
| EPS | ₹18.60 | — | ₹20.44 | ₹21.91 |
| Operating Profit | ₹351.3 Cr | ₹315.3 Cr | ₹377.7 Cr | ₹407.2 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 10 Nov 2025 | Interim Dividend - Rs 28 Per Share | INTERIM_DIVIDEND |
| 06 Nov 2024 | Interim Dividend - Rs 28 Per Share | INTERIM_DIVIDEND |
| 30 May 2024 | Buy Back | BUYBACK |
| 08 Feb 2024 | Interim Dividend - Rs 26 Per Share | INTERIM_DIVIDEND |
| 04 Aug 2023 | Interim Dividend - Rs 10 Per Share/Special Dividend - Rs 15 Per Share | SPECIAL_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for AJANTPHARM
View All
Stocks to watch: Ajanta Pharma, Bharti Airtel, IndiGo, NLC India, among key stocks in focus on 10 June - Mint
Stocks to watch: Ajanta Pharma, Bharti Airtel, IndiGo, NLC India, among key stocks in focus on 10 JuneMint
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but uncertainty persists due to mixed heavyweight stock trends. Investors are advised to focus on stock-specific opportunities as analysts maintain a cautious outlook.
Stocks to Watch for June 10: Bharti Airtel, Indigo, Ajanta Pharma, OMC stocks and more
Bharti Airtel gains relief after the Bombay High Court quashed OTSC demands, while IndiGo remains in focus following a 10% hike in aviation turbine fuel prices. Ajanta Pharma sees a promoter stake sale via a block deal, the government expands NLC India's OFS, and Dixon Technologies plans a telecom manufacturing joint venture with Gemtek. Here are the key stocks to watch ahead of Wednesday's trading session.